Do analysts rate CGC or ACB?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Canopy Growth 1 Sell rating(s) 3 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.17 Aurora Cannabis 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Do analysts recommend CRON or ACB?

Cronos Group currently has a consensus price target of $2.30, indicating a potential downside of 16.36%. Given Cronos Group's stronger consensus rating and higher probable upside, research analysts clearly believe Cronos Group is more favorable than Aurora Cannabis. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cronos Group 1 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.20 Aurora Cannabis 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Do analysts recommend ACB or OGI?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aurora Cannabis 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Organigram Global 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33

Do analysts prefer ACB or SNDL?

SNDL has a consensus target price of $5.00, suggesting a potential upside of 287.60%. Given SNDL's higher possible upside, analysts clearly believe SNDL is more favorable than Aurora Cannabis. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aurora Cannabis 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 SNDL 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has better earnings & valuation, ACB or SNDL?

SNDL has higher revenue and earnings than Aurora Cannabis. SNDL is trading at a lower price-to-earnings ratio than Aurora Cannabis, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Aurora Cannabis $247.82M 0.64 -$88.13M -$1.56 N/A SNDL $677.32M 0.49 -$11.29M -$0.03 N/A

Is ACB or SNDL more profitable?

SNDL has a net margin of -1.19% compared to Aurora Cannabis' net margin of -33.57%. Aurora Cannabis' return on equity of 0.10% beat SNDL's return on equity. Company Net Margins Return on Equity Return on Assets Aurora Cannabis -33.57% 0.10% 0.07% SNDL -1.19% -1.02% -0.85%

Do analysts recommend ACB or TLRY?

Tilray Brands has a consensus target price of $11.00, suggesting a potential upside of 152.87%. Given Tilray Brands' stronger consensus rating and higher possible upside, analysts clearly believe Tilray Brands is more favorable than Aurora Cannabis. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aurora Cannabis 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Tilray Brands 1 Sell rating(s) 4 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.25

Aurora Cannabis (ACB) Competitors

$2.58 -0.08 (-3.01%)

Closing price 07/16/2026 04:00 PM Eastern

Extended Trading

$2.58 0.00 (-0.19%)

As of 07/16/2026 07:59 PM Eastern

Compare

ACB vs. CGC, CRON, OGI, SNDL, and TLRY

Should you buy Aurora Cannabis stock or one of its competitors? MarketBeat compares Aurora Cannabis with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Aurora Cannabis include Canopy Growth (CGC), Cronos Group (CRON), Organigram Global (OGI), SNDL (SNDL), and Tilray Brands (TLRY). These companies are all part of the "pharmaceutical products" industry.

How does Aurora Cannabis compare to Canopy Growth?

Canopy Growth (NASDAQ:CGC) and Aurora Cannabis (NASDAQ:ACB) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, dividends, risk, institutional ownership, valuation, analyst recommendations, earnings and media sentiment.

Aurora Cannabis has a net margin of -33.57% compared to Canopy Growth's net margin of -75.27%. Aurora Cannabis' return on equity of 0.10% beat Canopy Growth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Canopy Growth	-75.27%	-26.95%	-17.20%
Aurora Cannabis	-33.57%	0.10%	0.07%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Canopy Growth	1 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.17
Aurora Cannabis	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

3.3% of Canopy Growth shares are held by institutional investors. Comparatively, 47.6% of Aurora Cannabis shares are held by institutional investors. 0.2% of Canopy Growth shares are held by insiders. Comparatively, 0.0% of Aurora Cannabis shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, Canopy Growth had 1 more articles in the media than Aurora Cannabis. MarketBeat recorded 2 mentions for Canopy Growth and 1 mentions for Aurora Cannabis. Canopy Growth's average media sentiment score of 0.82 beat Aurora Cannabis' score of 0.47 indicating that Canopy Growth is being referred to more favorably in the media.

Company	Overall Sentiment
Canopy Growth	Positive
Aurora Cannabis	Neutral

Canopy Growth has a beta of 0.79, meaning that its stock price is 21% less volatile than the broader market. Comparatively, Aurora Cannabis has a beta of 0.57, meaning that its stock price is 43% less volatile than the broader market.

Aurora Cannabis has lower revenue, but higher earnings than Canopy Growth. Aurora Cannabis is trading at a lower price-to-earnings ratio than Canopy Growth, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Canopy Growth	$251.01M	1.66	-$190.29M	-$0.59	N/A
Aurora Cannabis	$247.82M	0.64	-$88.13M	-$1.56	N/A

Summary

Canopy Growth beats Aurora Cannabis on 10 of the 15 factors compared between the two stocks.

How does Aurora Cannabis compare to Cronos Group?

Cronos Group (NASDAQ:CRON) and Aurora Cannabis (NASDAQ:ACB) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their earnings, institutional ownership, dividends, media sentiment, profitability, analyst recommendations, risk and valuation.

In the previous week, Cronos Group had 3 more articles in the media than Aurora Cannabis. MarketBeat recorded 4 mentions for Cronos Group and 1 mentions for Aurora Cannabis. Aurora Cannabis' average media sentiment score of 0.47 beat Cronos Group's score of 0.33 indicating that Aurora Cannabis is being referred to more favorably in the news media.

Company	Overall Sentiment
Cronos Group	Neutral
Aurora Cannabis	Neutral

Cronos Group has a beta of 0.89, suggesting that its share price is 11% less volatile than the broader market. Comparatively, Aurora Cannabis has a beta of 0.57, suggesting that its share price is 43% less volatile than the broader market.

Cronos Group has higher earnings, but lower revenue than Aurora Cannabis. Aurora Cannabis is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cronos Group	$146.59M	7.00	-$9.45M	$0.01	275.00
Aurora Cannabis	$247.82M	0.64	-$88.13M	-$1.56	N/A

Cronos Group currently has a consensus price target of $2.30, indicating a potential downside of 16.36%. Given Cronos Group's stronger consensus rating and higher probable upside, research analysts clearly believe Cronos Group is more favorable than Aurora Cannabis.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cronos Group	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.20
Aurora Cannabis	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Cronos Group has a net margin of -1.14% compared to Aurora Cannabis' net margin of -33.57%. Aurora Cannabis' return on equity of 0.10% beat Cronos Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cronos Group	-1.14%	-1.26%	-1.20%
Aurora Cannabis	-33.57%	0.10%	0.07%

8.7% of Cronos Group shares are owned by institutional investors. Comparatively, 47.6% of Aurora Cannabis shares are owned by institutional investors. 7.8% of Cronos Group shares are owned by insiders. Comparatively, 0.0% of Aurora Cannabis shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

Cronos Group beats Aurora Cannabis on 11 of the 16 factors compared between the two stocks.

How does Aurora Cannabis compare to Organigram Global?

Aurora Cannabis (NASDAQ:ACB) and Organigram Global (NASDAQ:OGI) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, institutional ownership, profitability, dividends, analyst recommendations, media sentiment and valuation.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aurora Cannabis	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Organigram Global	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

In the previous week, Organigram Global had 1 more articles in the media than Aurora Cannabis. MarketBeat recorded 2 mentions for Organigram Global and 1 mentions for Aurora Cannabis. Organigram Global's average media sentiment score of 1.28 beat Aurora Cannabis' score of 0.47 indicating that Organigram Global is being referred to more favorably in the news media.

Company	Overall Sentiment
Aurora Cannabis	Neutral
Organigram Global	Positive

47.6% of Aurora Cannabis shares are owned by institutional investors. Comparatively, 34.6% of Organigram Global shares are owned by institutional investors. 0.0% of Aurora Cannabis shares are owned by insiders. Comparatively, 0.1% of Organigram Global shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Aurora Cannabis has a beta of 0.57, indicating that its share price is 43% less volatile than the broader market. Comparatively, Organigram Global has a beta of 1.45, indicating that its share price is 45% more volatile than the broader market.

Organigram Global has lower revenue, but higher earnings than Aurora Cannabis. Organigram Global is trading at a lower price-to-earnings ratio than Aurora Cannabis, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aurora Cannabis	$247.82M	0.64	-$88.13M	-$1.56	N/A
Organigram Global	$185.07M	0.66	-$17.70M	-$0.13	N/A

Organigram Global has a net margin of -9.22% compared to Aurora Cannabis' net margin of -33.57%. Aurora Cannabis' return on equity of 0.10% beat Organigram Global's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aurora Cannabis	-33.57%	0.10%	0.07%
Organigram Global	-9.22%	-13.41%	-9.09%

Summary

Organigram Global beats Aurora Cannabis on 10 of the 15 factors compared between the two stocks.

How does Aurora Cannabis compare to SNDL?

Aurora Cannabis (NASDAQ:ACB) and SNDL (NASDAQ:SNDL) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, earnings, media sentiment, analyst recommendations, institutional ownership, valuation, dividends and profitability.

SNDL has higher revenue and earnings than Aurora Cannabis. SNDL is trading at a lower price-to-earnings ratio than Aurora Cannabis, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aurora Cannabis	$247.82M	0.64	-$88.13M	-$1.56	N/A
SNDL	$677.32M	0.49	-$11.29M	-$0.03	N/A

In the previous week, SNDL had 4 more articles in the media than Aurora Cannabis. MarketBeat recorded 5 mentions for SNDL and 1 mentions for Aurora Cannabis. SNDL's average media sentiment score of 0.75 beat Aurora Cannabis' score of 0.47 indicating that SNDL is being referred to more favorably in the news media.

Company	Overall Sentiment
Aurora Cannabis	Neutral
SNDL	Positive

47.6% of Aurora Cannabis shares are held by institutional investors. 0.0% of Aurora Cannabis shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

SNDL has a consensus target price of $5.00, suggesting a potential upside of 287.60%. Given SNDL's higher possible upside, analysts clearly believe SNDL is more favorable than Aurora Cannabis.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aurora Cannabis	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
SNDL	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Aurora Cannabis has a beta of 0.57, meaning that its stock price is 43% less volatile than the broader market. Comparatively, SNDL has a beta of 0.92, meaning that its stock price is 8% less volatile than the broader market.

SNDL has a net margin of -1.19% compared to Aurora Cannabis' net margin of -33.57%. Aurora Cannabis' return on equity of 0.10% beat SNDL's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aurora Cannabis	-33.57%	0.10%	0.07%
SNDL	-1.19%	-1.02%	-0.85%

Summary

SNDL beats Aurora Cannabis on 8 of the 14 factors compared between the two stocks.

How does Aurora Cannabis compare to Tilray Brands?

Aurora Cannabis (NASDAQ:ACB) and Tilray Brands (NASDAQ:TLRY) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, profitability, media sentiment, risk, institutional ownership, earnings, dividends and analyst recommendations.

In the previous week, Tilray Brands had 20 more articles in the media than Aurora Cannabis. MarketBeat recorded 21 mentions for Tilray Brands and 1 mentions for Aurora Cannabis. Tilray Brands' average media sentiment score of 0.69 beat Aurora Cannabis' score of 0.47 indicating that Tilray Brands is being referred to more favorably in the news media.

Company	Overall Sentiment
Aurora Cannabis	Neutral
Tilray Brands	Positive

Tilray Brands has a consensus target price of $11.00, suggesting a potential upside of 152.87%. Given Tilray Brands' stronger consensus rating and higher possible upside, analysts clearly believe Tilray Brands is more favorable than Aurora Cannabis.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aurora Cannabis	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Tilray Brands	1 Sell rating(s)	4 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.25

47.6% of Aurora Cannabis shares are held by institutional investors. Comparatively, 9.4% of Tilray Brands shares are held by institutional investors. 0.0% of Aurora Cannabis shares are held by company insiders. Comparatively, 0.8% of Tilray Brands shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Aurora Cannabis has higher earnings, but lower revenue than Tilray Brands. Aurora Cannabis is trading at a lower price-to-earnings ratio than Tilray Brands, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aurora Cannabis	$247.82M	0.64	-$88.13M	-$1.56	N/A
Tilray Brands	$821.31M	0.62	-$2.19B	-$13.65	N/A

Aurora Cannabis has a beta of 0.57, indicating that its stock price is 43% less volatile than the broader market. Comparatively, Tilray Brands has a beta of 1.89, indicating that its stock price is 89% more volatile than the broader market.

Aurora Cannabis has a net margin of -33.57% compared to Tilray Brands' net margin of -156.51%. Aurora Cannabis' return on equity of 0.10% beat Tilray Brands' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aurora Cannabis	-33.57%	0.10%	0.07%
Tilray Brands	-156.51%	-3.31%	-2.42%

Summary

Tilray Brands beats Aurora Cannabis on 9 of the 16 factors compared between the two stocks.

Get Aurora Cannabis News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ACB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ACB vs. The Competition

Export

Metric	Aurora Cannabis	MED PRODUCTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$163.18M	$8.56B	$6.96B	$12.67B
Dividend Yield	N/A	2.56%	2.68%	8.87%
P/E Ratio	-1.65	16.05	27.21	24.05
Price / Sales	0.64	6.95	519.51	89.73
Price / Cash	3.79	18.07	49.25	59.89
Price / Book	0.41	3.31	10.78	6.23
Net Income	-$88.13M	$228.19M	$3.59B	$331.94M
7 Day Performance	-4.80%	-2.10%	-2.55%	-1.93%
1 Month Performance	-11.64%	-1.43%	2.81%	-0.97%
1 Year Performance	-43.30%	-0.73%	25.42%	18.24%

Aurora Cannabis Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ACB Aurora Cannabis	1.2008 of 5 stars	$2.58 -3.0%	N/A	-42.4%	$163.18M	$247.82M	N/A	1,028
CGC Canopy Growth	0.9794 of 5 stars	$0.96 -1.2%	N/A	-15.7%	$435.50M	$251.01M	N/A	1,128	Analyst Downgrade
CRON Cronos Group	1.6269 of 5 stars	$2.75 flat	$2.30 -16.4%	+36.8%	$1.03B	$146.59M	275.28	450	News Coverage
OGI Organigram Global	1.3527 of 5 stars	$0.90 -7.3%	N/A	-40.3%	$136.11M	$185.07M	N/A	1,139	Positive News High Trading Volume
SNDL SNDL	4.0668 of 5 stars	$1.31 flat	$5.00 +281.7%	-13.4%	$337.19M	$677.32M	N/A	2,751	News Coverage

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ACB) was last updated on 7/17/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Aurora Cannabis (ACB) Competitors

ACB vs. CGC, CRON, OGI, SNDL, and TLRY

How does Aurora Cannabis compare to Canopy Growth?

Summary

How does Aurora Cannabis compare to Cronos Group?

Summary

How does Aurora Cannabis compare to Organigram Global?

Summary

How does Aurora Cannabis compare to SNDL?

Summary

How does Aurora Cannabis compare to Tilray Brands?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ACB vs. The Competition

Aurora Cannabis Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Aurora Cannabis (ACB) Competitors

ACB vs. CGC, CRON, OGI, SNDL, and TLRY

How does Aurora Cannabis compare to Canopy Growth?

Is CGC or ACB more profitable?

Do analysts rate CGC or ACB?

Do insiders and institutionals have more ownership in CGC or ACB?

Does the media favor CGC or ACB?

Which has more volatility & risk, CGC or ACB?

Which has better valuation & earnings, CGC or ACB?

Summary

How does Aurora Cannabis compare to Cronos Group?

Does the media prefer CRON or ACB?

Which has more risk & volatility, CRON or ACB?

Which has better valuation and earnings, CRON or ACB?

Do analysts recommend CRON or ACB?

Is CRON or ACB more profitable?

Do insiders and institutionals have more ownership in CRON or ACB?

Summary

How does Aurora Cannabis compare to Organigram Global?

Do analysts recommend ACB or OGI?

Does the media refer more to ACB or OGI?

Do institutionals and insiders believe in ACB or OGI?

Which has more volatility and risk, ACB or OGI?

Which has higher earnings & valuation, ACB or OGI?

Is ACB or OGI more profitable?

Summary

How does Aurora Cannabis compare to SNDL?

Which has better earnings & valuation, ACB or SNDL?

Does the media favor ACB or SNDL?

Do insiders & institutionals believe in ACB or SNDL?

Do analysts prefer ACB or SNDL?

Which has more volatility & risk, ACB or SNDL?

Is ACB or SNDL more profitable?

Summary

How does Aurora Cannabis compare to Tilray Brands?

Does the media favor ACB or TLRY?

Do analysts recommend ACB or TLRY?

Do institutionals and insiders hold more shares of ACB or TLRY?

Which has preferable valuation & earnings, ACB or TLRY?

Which has more volatility and risk, ACB or TLRY?

Is ACB or TLRY more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ACB vs. The Competition

Aurora Cannabis Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools